Based on breast cancer risk, including factors such as age at cancer diagnosis, breast density, and family history, women with a personal history of cancer may undergo MRI for the contralateral native breast [17]. In this setting, MRI will also allow for evaluation of the reconstructed breast and may be able to demonstrate recurrent malignancy, although the literature is scant with only several small studies and case reports [30,31]. Reiber et al [31], for example, used MRI to evaluate 41 patients with flap reconstructions, finding one mammographically and sonographically occult cancer in a patient with a latissimus dorsi flap. However, MRI also generated three false- positive biopsies. Sestamibi MBI There is no relevant literature to support the use of Tc-99m sestamibi MBI for screening in this clinical setting. US Breast There is no relevant literature to support the use of US for screening in this clinical setting. Imaging after Mastectomy and Breast Reconstruction Digital Breast Tomosynthesis Screening There is no relevant literature to support the use of DBT for screening in this clinical setting. Mammography Screening There is no relevant literature to support the use of mammography for screening in this clinical setting. FDG-PET Breast Dedicated There is no relevant literature to support the use of FDG-PET breast for screening in this clinical setting. MRI Breast Without IV Contrast There is no relevant literature to support the use of MRI without IV contrast for screening in this clinical setting. Sestamibi MBI There is no relevant literature to support the use of Tc-99m sestamibi MBI for screening in this clinical setting. US Breast There is no relevant literature to support the use of US for screening in this clinical setting. FDG-PET Breast Dedicated There is no relevant literature to support the use of FDG-PET breast for screening in this clinical setting.
Imaging after Mastectomy and Breast Reconstruction. Based on breast cancer risk, including factors such as age at cancer diagnosis, breast density, and family history, women with a personal history of cancer may undergo MRI for the contralateral native breast [17]. In this setting, MRI will also allow for evaluation of the reconstructed breast and may be able to demonstrate recurrent malignancy, although the literature is scant with only several small studies and case reports [30,31]. Reiber et al [31], for example, used MRI to evaluate 41 patients with flap reconstructions, finding one mammographically and sonographically occult cancer in a patient with a latissimus dorsi flap. However, MRI also generated three false- positive biopsies. Sestamibi MBI There is no relevant literature to support the use of Tc-99m sestamibi MBI for screening in this clinical setting. US Breast There is no relevant literature to support the use of US for screening in this clinical setting. Imaging after Mastectomy and Breast Reconstruction Digital Breast Tomosynthesis Screening There is no relevant literature to support the use of DBT for screening in this clinical setting. Mammography Screening There is no relevant literature to support the use of mammography for screening in this clinical setting. FDG-PET Breast Dedicated There is no relevant literature to support the use of FDG-PET breast for screening in this clinical setting. MRI Breast Without IV Contrast There is no relevant literature to support the use of MRI without IV contrast for screening in this clinical setting. Sestamibi MBI There is no relevant literature to support the use of Tc-99m sestamibi MBI for screening in this clinical setting. US Breast There is no relevant literature to support the use of US for screening in this clinical setting. FDG-PET Breast Dedicated There is no relevant literature to support the use of FDG-PET breast for screening in this clinical setting.